Pharmacom ApS — Credit Rating and Financial Key Figures

CVR number: 40251480
Betonvej 10, 4000 Roskilde
adm@pharmacom.dk

Income statement (kDKK)

2019
2020
2021
2022
Fiscal period length12121212
Net sales
Gross profit27.002 485.00778.00836.73
Employee benefit expenses- 760.00- 649.00- 788.78
Total depreciation-85.00-76.00-28.22
EBIT27.001 640.0053.0019.73
Other financial expenses-27.00-36.00-5.99
Pre-tax profit27.001 613.0017.0013.75
Income taxes-10.00- 358.00-6.00-5.40
Net earnings17.001 255.0011.008.35

Assets (kDKK)

2019
2020
2021
2022
Intangible assets total
Machinery and equipment325.00101.00
Tangible assets total325.00101.00
Investments total
Long term receivables total
Inventories total
Prepayments and accrued income8.0030.00
Current other receivables59.00464.0040.00
Current deferred tax assets8.0034.26
Short term receivables total59.00472.0078.0034.26
Cash and bank deposits372.001 053.00702.00324.75
Cash and cash equivalents372.001 053.00702.00324.75
Balance sheet total (assets)431.001 850.00881.00359.01

Equity and liabilities (kDKK)

2019
2020
2021
2022
Share capital50.0050.0050.0050.00
Shares repurchased1 250.0040.00
Retained earnings-1 233.0022.00-7.89
Profit of the financial year17.001 255.0011.008.35
Shareholders equity total67.001 322.0083.0090.45
Provisions4.00
Non-current liabilities total
Current trade creditors100.00622.00
Current owed to participating20.31
Short-term deferred tax liabilities10.00364.0015.00
Other non-interest bearing current liabilities333.6960.00161.00268.55
Current liabilities total364.00524.00798.00268.55
Balance sheet total (liabilities)431.001 850.00881.00359.01
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.